From: Improvement of quality of life through glycemic control by liraglutide, a GLP-1 analog, in insulin-naive patients with type 2 diabetes mellitus: the PAGE1 study
Dose (mg)
Baseline (n = 204)
Week 12 (n = 204)
0.3
186 (91.2)
19 (9.3)
0.6
3 (1.5)
28 (13.7)
0.9
15 (7.4)
157 (77.0)